STOCK TITAN

abrdn World Healthcare Fund - THW STOCK NEWS

Welcome to our dedicated news page for abrdn World Healthcare Fund (Ticker: THW), a resource for investors and traders seeking the latest updates and insights on abrdn World Healthcare Fund.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect abrdn World Healthcare Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of abrdn World Healthcare Fund's position in the market.

Rhea-AI Summary
abrdn U.S. Closed-End Funds (ASGI) announced distributions to shareholders on February 29, 2024. The Funds paid $0.1500 per share for abrdn Global Infrastructure Income Fund (ASGI), $0.1800 for abrdn Healthcare Opportunities Fund (THQ), and $0.1167 for abrdn World Healthcare Fund (THW). The distributions aim to provide stable income from current income, capital gains, and paid-in capital. The estimated sources of distributions include net investment income, short-term and long-term capital gains, and return of capital. Shareholders are cautioned that a return of capital does not reflect investment performance. The Funds' total return performance and distribution rates are also provided for investor reference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
-
Rhea-AI Summary
abrdn U.S. Closed-End Funds (ASGI) announced distributions on November 30, 2023. ASGI distributed $0.1200 per share, THQ distributed $0.1125, and THW distributed $0.1167. The funds adopted a distribution policy for stable distribution out of current income, supplemented by realized capital gains and paid-in capital. The estimated sources of the distributions and the Funds' total return performance are detailed in the PR.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
none
-
Rhea-AI Summary
abrdn World Healthcare Fund, formerly known as Tekla World Healthcare Fund, paid a monthly distribution of $0.1167 per share on October 31, 2023. The distribution is derived from a return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains, so a portion of the distribution may be a return of capital. The Fund's average annual return at NAV for the period from September 30, 2018, through September 30, 2023, was 5.18%. The annualized current distribution rate is 11.94% of NAV as of September 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.26%
Tags
none
Rhea-AI Summary
Tekla World Healthcare Fund declares monthly cash distribution
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
none
-
Rhea-AI Summary
Tekla World Healthcare Fund declares monthly cash distribution of $0.1167 per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.87%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
none
abrdn World Healthcare Fund

NYSE:THW

THW Rankings

THW Stock Data

464.60M
0%
11.83%
0.75%
Asset Management
Financial Services
Link
US
Boston

About THW

tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form